Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jonathan G. Stine & Patrick G. Northup. (2016) Autoimmune-like drug-induced liver injury: a review and update for the clinician. Expert Opinion on Drug Metabolism & Toxicology 12:11, pages 1291-1301.
Read now
Read now
Yue-Ming Wang, Sergio C Chai, Christopher T Brewer & Taosheng Chen. (2014) Pregnane X receptor and drug-induced liver injury. Expert Opinion on Drug Metabolism & Toxicology 10:11, pages 1521-1532.
Read now
Read now
Walid M Chalhoub, Kayla D Sliman, Meera Arumuganathan & James H Lewis. (2014) Drug-induced liver injury: what was new in 2013?. Expert Opinion on Drug Metabolism & Toxicology 10:7, pages 959-980.
Read now
Read now
Yong Zhou, Shizhen Qin & Kai Wang. (2013) Biomarkers of drug-induced liver injury. Current Biomarker Findings 3, pages 1-9.
Read now
Read now
Articles from other publishers (43)
Rohit Sharma & Pradeep K. Prajapati. (2022) Remarks on “Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series”. Journal of Clinical and Experimental Hepatology 12:1, pages 247-248.
Crossref
Crossref
Narendra Kumar, Salim Surani, George Udeani, Sara Mathew, Sharon John, Soniya Sajan & Jayshree Mishra. (2021) Drug-induced liver injury and prospect of cytokine based therapy; A focus on IL-2 based therapies. Life Sciences 278, pages 119544.
Crossref
Crossref
Shunmin Huang, Maobai Liu, Fangmeng Fu, Hangmin Liu, Baochang He, Danni Xiao & Jing Yang. (2021) High Serum Estradiol Reduces Acute Hepatotoxicity Risk Induced by Epirubicin Plus Cyclophosphamide Chemotherapy in Premenopausal Women with Breast Cancer. Frontiers in Pharmacology 11.
Crossref
Crossref
Shunmin Huang, Jing Yang, Fangmeng Fu, Chuan Wang, Xiaoxiong Guo, Baochang He, Danni Xiao, Hongfu Cai & Maobai Liu. (2021) Clinical and genetic risk factors for the prediction of hepatotoxicity induced by a docetaxel, epirubicin and cyclophosphamide regimen in breast cancer patients. Pharmacogenomics 22:2, pages 87-98.
Crossref
Crossref
Lu Li, Sujun Zheng & Yu Chen. (2019) Stevens–Johnson syndrome and acute vanishing bile duct syndrome after the use of amoxicillin and naproxen in a child. Journal of International Medical Research 47:9, pages 4537-4543.
Crossref
Crossref
Felix Hammann, Verena Schöning & Jürgen Drewe. (2019) Prediction of clinically relevant drug-induced liver injury from structure using machine learning. Journal of Applied Toxicology 39:3, pages 412-419.
Crossref
Crossref
He Tingting, Zhu Yun, Wang Jiabo, Gong Man, Wang Ruilin, Niu Ming, Jing Jing, Wang Lifu, Wang Zhongxia, Zhang Ning, Bai Zhaofang, Bai Yunfeng, Li Yonggang & Xiao Xiaohe. (2017) Clinical characteristics of 96 patients with drug-induced acute liver failure: a comparison between Traditional Chinese and Western Medicine. Journal of Traditional Chinese Medicine 37:3, pages 286-297.
Crossref
Crossref
Yue-cheng Yu, Yi-min Mao, Cheng-wei Chen, Jin-jun Chen, Jun Chen, Wen-ming Cong, Yang Ding, Zhong-ping Duan, Qing-chun Fu, Xiao-yan Guo, Peng Hu, Xi-qi Hu, Ji-dong Jia, Rong-tao Lai, Dong-liang Li, Ying-xia Liu, Lun-gen Lu, Shi-wu Ma, Xiong Ma, Yue-min Nan, Hong Ren, Tao Shen, Hao Wang, Ji-yao Wang, Tai-ling Wang, Xiao-jin Wang, Lai Wei, Qing Xie, Wen Xie, Chang-qing Yang, Dong-liang Yang, Yan-yan Yu, Min-de Zeng, Li Zhang, Xin-yan Zhao & Hui Zhuang. (2017) CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatology International 11:3, pages 221-241.
Crossref
Crossref
Yehudit Shabat & Yaron Ilan. (2017) A synergistic effect of Cremophor and beta glucosylceramide to exert liver and sugar protection. Journal of Food Science and Technology 54:5, pages 1184-1191.
Crossref
Crossref
Young-Eun Cho, Eun-Ju Im, Pyong-Gon Moon, Esteban Mezey, Byoung-Joon Song & Moon-Chang Baek. (2017) Increased liver-specific proteins in circulating extracellular vesicles as potential biomarkers for drug- and alcohol-induced liver injury. PLOS ONE 12:2, pages e0172463.
Crossref
Crossref
Jonathan G. Stine & Naga P. Chalasani. (2017) Drug Hepatotoxicity. Clinics in Liver Disease 21:1, pages 103-113.
Crossref
Crossref
Tamara Alempijevic, Simon Zec & Tomica Milosavljevic. (2017) Drug-induced liver injury: Do we know everything?. World Journal of Hepatology 9:10, pages 491.
Crossref
Crossref
Maria Virginia Caballero, Ramon A. Espinoza‐Lewis & Manila Candiracci. 2016. Stem Cells in Toxicology and Medicine. Stem Cells in Toxicology and Medicine
5
25
.
Ahmet Basturk, Reha Artan, Aygen Yılmaz, Mustafa T. Gelen & Ozgur Duman. (2016) Acute vanishing bile duct syndrome after the use of ibuprofen. Arab Journal of Gastroenterology 17:3, pages 137-139.
Crossref
Crossref
María José Gómez-Lechón & Laia Tolosa. (2016) Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening. Archives of Toxicology 90:9, pages 2049-2061.
Crossref
Crossref
Edward Spack. 2016. Regenerative Medicine - from Protocol to Patient. Regenerative Medicine - from Protocol to Patient
51
82
.
Maria Suciu, Alexandra T. Gruia, Dragos V. Nica, Seyed M.R. Azghadi, Ani A. Mic & Felix A. Mic. (2015) Acetaminophen-induced liver injury: Implications for temporal homeostasis of lipid metabolism and eicosanoid signaling pathway. Chemico-Biological Interactions 242, pages 335-344.
Crossref
Crossref
Jonathan G. Stine & Naga Chalasani. (2015) Chronic liver injury induced by drugs: a systematic review. Liver International 35:11, pages 2343-2353.
Crossref
Crossref
James H. Lewis. (2015) The Art and Science of Diagnosing and Managing Drug-induced Liver Injury in 2015 and Beyond. Clinical Gastroenterology and Hepatology 13:12, pages 2173-2189.e8.
Crossref
Crossref
J Jiang, X Zhang, R Huo, X Li, Y Yang, Z Gai, M Xu, L Shen, L Cai, C Wan, B Li, L He & S Qin. (2014) Association study of UGT1A9 promoter polymorphisms with DILI based on systematically regional variation screen in Chinese population. The Pharmacogenomics Journal 15:4, pages 326-331.
Crossref
Crossref
Jonathan G. Stine, Nicolas Intagliata, Neeral L. Shah, Curtis K. Argo, Stephen H. Caldwell, James H. Lewis & Patrick G. Northup. (2014) Hepatic Decompensation Likely Attributable to Simeprevir in Patients with Advanced Cirrhosis. Digestive Diseases and Sciences 60:4, pages 1031-1035.
Crossref
Crossref
Rachel P. L. van Swelm, Mackenzie Hadi, Coby M. M. Laarakkers, Rosalinde Masereeuw, Geny M. M. Groothuis & Frans G. M. Russel. (2014) Proteomic profiling in incubation medium of mouse, rat and human precision-cut liver slices for biomarker detection regarding acute drug-induced liver injury. Journal of Applied Toxicology 34:9, pages 993-1001.
Crossref
Crossref
Getnet Yimer, Marcus Gry, Wondwossen Amogne, Eyasu Makonnen, Abiy Habtewold, Zelalem Petros, Getachew Aderaye, Ina Schuppe-Koistinen, Lars Lindquist & Eleni Aklillu. (2014) Evaluation of Patterns of Liver Toxicity in Patients on Antiretroviral and Anti-Tuberculosis Drugs: A Prospective Four Arm Observational Study in Ethiopian Patients. PLoS ONE 9:4, pages e94271.
Crossref
Crossref
Hye-young KimHea Kyoung YangSeong Heon KimJae Hong Park. (2014) Ibuprofen Associated Acute Vanishing Bile Duct Syndrome and Toxic Epidermal Necrolysis in an Infant. Yonsei Medical Journal 55:3, pages 834.
Crossref
Crossref
Oksana SirenkoJayne HesleyIvan RusynEvan F. Cromwell. (2014) High-Content Assays for Hepatotoxicity Using Induced Pluripotent Stem Cell–Derived Cells. ASSAY and Drug Development Technologies 12:1, pages 43-54.
Crossref
Crossref
Yuping Wang, Jurgen Borlak & Weida Tong. 2014. Genomic Biomarkers for Pharmaceutical Development. Genomic Biomarkers for Pharmaceutical Development
127
155
.
Ji Won Kim, Sung Ha Ryu, Siwon Kim, Hae Won Lee, Mi-sun Lim, Sook Jin Seong, Suhkmann Kim, Young-Ran Yoon & Kyu-Bong Kim. (2013)
Pattern Recognition Analysis for Hepatotoxicity Induced by Acetaminophen Using Plasma and Urinary
1
H NMR-Based Metabolomics in Humans
. Analytical Chemistry 85:23, pages 11326-11334.
Crossref
Crossref
Chung‐Te Liu, Tso‐Hsiao Chen & Chung‐Yi Cheng. (2013) Successful treatment of drug‐induced acute liver failure with high‐volume plasma exchange. Journal of Clinical Apheresis 28:6, pages 430-434.
Crossref
Crossref
Ryan E. Morgan, Carlo J. van Staden, Yuan Chen, Natarajan Kalyanaraman, Jackson Kalanzi, Robert T. DunnIIII, Cynthia A. Afshari & Hisham K. Hamadeh. (2013) A Multifactorial Approach to Hepatobiliary Transporter Assessment Enables Improved Therapeutic Compound Development. Toxicological Sciences 136:1, pages 216-241.
Crossref
Crossref
James H. Lewis. (2013) Drug-Induced Liver Injury Throughout the Drug Development Life Cycle: Where We Have Been, Where We are Now, and Where We are Headed. Perspectives of a Clinical Hepatologist. Pharmaceutical Medicine 27:3, pages 165-191.
Crossref
Crossref
E. Ocete Hita, J.A. Martín García, F. Giménez Sánchez, J.C. Flores González, A. Abril Molina, J. Salmerón Escobar & A. Ruiz Extremera. (2013) Hepatotoxicidad por fármacos o productos naturales en niños. Anales de Pediatría 78:4, pages 248-259.
Crossref
Crossref
Bernardo Frider, Andres Bruno, Marcelo Ponte & Marcelo Amante. (2013) Drug-Induced Liver Injury Caused by Adalimumab: A Case Report and Review of the Bibliography. Case Reports in Hepatology 2013, pages 1-3.
Crossref
Crossref
S. Messner, I. Agarkova, W. Moritz & J. M. Kelm. (2012) Multi-cell type human liver microtissues for hepatotoxicity testing. Archives of Toxicology 87:1, pages 209-213.
Crossref
Crossref
Rachel P. L. van Swelm, Coby M. M. Laarakkers, Ellen C. van der Kuur, Eva Morava-Kozicz, Ron A. Wevers, Kevin D. Augustijn, Daan J. Touw, Maro H. Sandel, Rosalinde Masereeuw & Frans G. M. Russel. (2012) Identification of Novel Translational Urinary Biomarkers for Acetaminophen-Induced Acute Liver Injury Using Proteomic Profiling in Mice. PLoS ONE 7:11, pages e49524.
Crossref
Crossref
Carlo J. Staden, Ryan E. Morgan, Bharath Ramachandran, Yuan Chen, Paul H. Lee & Hisham K. Hamadeh. (2012) Membrane Vesicle ABC Transporter Assays for Drug Safety Assessment. Current Protocols in Toxicology 54:1.
Crossref
Crossref
A Alfirevic & M Pirmohamed. (2012) Predictive Genetic Testing for Drug-Induced Liver Injury: Considerations of Clinical Utility. Clinical Pharmacology & Therapeutics 92:3, pages 376-380.
Crossref
Crossref
Sabina Mugusi, Eliford Ngaimisi, Mohamed Janabi, Omary Minzi, Muhammad Bakari, Klaus-Dieter Riedel, Juergen Burhenne, Lars Lindquist, Ferdinand Mugusi, Eric Sandstrom & Eleni Aklillu. (2012) Liver Enzyme Abnormalities and Associated Risk Factors in HIV Patients on Efavirenz-Based HAART with or without Tuberculosis Co-Infection in Tanzania. PLoS ONE 7:7, pages e40180.
Crossref
Crossref
Rolf Teschke, Christian Frenzel, Johannes Schulze & Axel Eickhoff. (2012) Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: Was causality adequately ascertained?. Regulatory Toxicology and Pharmacology 63:1, pages 1-9.
Crossref
Crossref
Rolf Teschke, Xaver Glass, Johannes Schulze & Axel Eickhoff. (2012) Suspected Greater Celandine hepatotoxicity. European Journal of Gastroenterology & Hepatology 24:3, pages 270-280.
Crossref
Crossref
Xi Yang, James Greenhaw, Qiang Shi, Zhenqiang Su, Feng Qian, Kelly Davis, Donna L. Mendrick & William F. Salminen. (2012) Identification of Urinary microRNA Profiles in Rats That May Diagnose Hepatotoxicity. Toxicological Sciences 125:2, pages 335-344.
Crossref
Crossref
Lars Edvinsson & Mattias Linde. (2012) CGRP antagonists for the treatment of migraine: rationale and clinical data. Clinical Investigation 2:1, pages 73-88.
Crossref
Crossref
Salim S. Virani & Christie M. Ballantyne. (2011) Update on therapies targeting HDL. Current Opinion in Lipidology 22:6, pages 514-516.
Crossref
Crossref
Rolf Teschke, Xaver Glass & Johannes Schulze. (2011) Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): Causality assessment of 22 spontaneous reports. Regulatory Toxicology and Pharmacology 61:3, pages 282-291.
Crossref
Crossref